Two anti-inflammatory drugs found that inhibit the replication of the COVID-19 virus

Researchers at the URV have used computer techniques to analyse whether 6,466 drugs authorized by various drug agencies for both human and veterinary use could be used to inhibit the M-pro enzyme. The study demonstrates that a human and a veterinary anti-inflammatory drug – Carprofen and Celecoxib – inhibit a key enzyme in the replication and transcription of the virus responsible for COVID-19. The results of the work have been validated by the initiative COVIDMoonshot.